Biomedical Excellence for Safer Transfusion
  • Biomedical Excellence for Safer Transfusion (BEST)
    Biomedical Excellence for Safer Transfusion (BEST)

    BEST Collaborative is an international research organization with a vision to lead the field of transfusion medicine and cellular therapies toward the best…

  • BEST Membership
    BEST Membership

    The BEST collaborative is a unique free-standing group of over 170 manufacturers, clinicians, and scientists from 22 countries committed to improving transfusion…

  • BEST Meetings
    BEST Meetings

    BEST meetings are held twice per year. and attendance is open to all members. Invited guests may attend with pre-approval of the Chair.

  • Press Releases
    Press Releases

    Official notices regarding significant publications, special events, and member news.

  • Recommended Procedures
    Recommended Procedures

    Several best practice documents are available for download

  • Sponsorship
    Sponsorship

    Any commercial organization or Blood Service interested in advancing the purpose of BEST may become a supporter of BEST by paying the annual dues amount; providing a…

Latest News

Call for Scott Murphy Memorial Lecture Applications

Applications for November 2021 Symposium are being accepted now thru August 31, 2021

Press Release 06 Mar 2021

Award Recipient of 26th Scott Murphy Memorial Award Lectureship Announced

Press Release 24 Aug 2020

Award Recipient of 25th Scott Murphy Memorial Award Lectureship Announced

Member News

  • BEST Meeting LXII  will be held in person in Los Angeles, California 13-14 October 2021 for those able and willing to travel. The meeting venue is the Marriott in Marina del Rey, located very close to LAX airport. The meeting RSVP will be available at a later date. We will be also hosting the meeting sessions on Zoom.
  • Members who wish to invite MEETING and/or CONFERENCE CALL guests must have the pre-approval of the Chair. Please submit your requests for approval well in advance of each event. Approved guests will receive a separate Registration & Dinner RSVP, as well as meeting materials, and must complete a Non-Disclosure Agreement (NDA). This applies to all Virtual Meetings as well.
  • Please be sure to keep your contact information on the website up to date so you can be assured of receiving our email updates.
 

Fall 2021

Calfornia

BEST LXII Meeting

The Fall 2021 Meeting is scheduled for 13-14 October 2021.
Important News:

  • The meeting location is the Marina del Rey Marriott, located very near LAX Airport. We will be closely monitoring the situation as circumstances arise.
  • Information on the hotel reservation block is now posted in the member's area.
  • As with all meetings, guests must be approved in advance by the Chair.

 

Spring 2022

Zoomlandia

BEST LXIII Meeting

The Spring 2022 Meeting is planned for Warsaw, Poland 22-23 April 2022.

Important News

  • We plan to hold the meeting in the Hotel Bristol with the BEST Dinner at the Royal Castle
  • Due to the continuing COVID-19 pandemic, we have no further details at this time.

 

A A A

BEST Collaborative is an international research organization with a vision to lead the field of transfusion medicine and cellular therapies toward the best products and practices for donors and patients.

We have 42 scientific members, 15 manufacturing sponsors, and 22 blood service sponsors from 22 countries representing a diversity of interests and high levels of accomplishment. The supporting members of BEST span a broad range of the companies and blood suppliers engaged with blood collection, distribution and transfusion worldwide. We also have been pleased to have some participation from regulatory agencies such as FDA and the Paul Ehrlich Institute. BEST has published 135 peer reviewed papers and has 40 studies currently open. As part of our mission, BEST believes it brings to the community thoughtful consideration to identify important questions in Transfusion Medicine, design and execute studies to address these questions, and provide critical thought and synthesis of the available evidence.